Abstract
The present Cochrane review included 23 studies randomized placebo-controlled clinical trials with a total of 1,255 patients. The effect of autologous cell therapy versus placebo was examined on left ventricular ejection fraction (LVEF), adverse effects and mortality in patients with chronic ischaemic heart disease. Patients treated with cell therapy had improved LVEF and functional status compared to patients who received placebo. There were no cell-related and only few procedure-related side effects. A positive effect of cell therapy on long-term survival was also demonstrated.
| Bidragets oversatte titel | Effect of cell therapy in patients with chronic ischaemic heart disease--a survey of a Cochrane review |
|---|---|
| Originalsprog | Dansk |
| Tidsskrift | Ugeskrift for Laeger |
| Vol/bind | 177 |
| Udgave nummer | 7 |
| Sider (fra-til) | 642-44 |
| ISSN | 0041-5782 |
| Status | Udgivet - 9 feb. 2015 |
Fingeraftryk
Dyk ned i forskningsemnerne om 'Effekten af cellebehandling hos patienter med kronisk iskæmisk hjertesygdom--en gennemgang af et Cochranereview'. Sammen danner de et unikt fingeraftryk.Citationsformater
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS